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et al., 2009). This meta-analytic method uses peaks of atrophy, 
hypometabolism, or hypoperfusion in patients with dementia if 
compared with control subjects, and determines brain regions that 
exhibit a higher density of peak coordinates reported across single 
studies than would arise by chance. The ALE map represents the 
prototypical neural correlates of a specific dementia syndrome.
For AD and its prodromal stage, amnestic mild cognitive impair-
ment (MCI), the meta-analysis revealed atrophy and reductions 
in metabolism and perfusion in a mainly temporoparietal net-
work related to episodic memory processing (Thompson et al., 
2003; Schroeter et al., 2009; McDonald et al., 2010; Walhovd et al., 
2010). AD additionally involved frontomedian-thalamic struc-
tures. Atrophy in the (trans-) entorhinal area/hippocampus, and 
hypometabolism/-perfusion in the inferior parietal lobules most 
reliably predicted the progression from amnestic MCI to AD, 
whereas decreases in metabolism and perfusion in the posterior cin-
gulate cortex and precuneus were unspecific (Schroeter et al., 2009).
For FTLD, the meta-analyses “triple dissociated” the prototypical 
neural substrates of its three subtypes (Neary et al., 1998; Schroeter 
et al., 2007, 2008). Frontotemporal dementia (FTD) – clinically 
characterized by changes in behavior and personality – affected a 
frontomedian network discussed in the context of social cognition. 
For the two other FTLD subtypes, the main clinical symptom is 
language impairment. Semantic dementia (SD) was related to the 
IntroductIon
Neurodegenerative disorders are a major public health problem 
(Dubois et al., 2007; Kipps et al., 2009). The early detection, predic-
tion, and dissociation of dementia syndromes are of paramount 
interest, in particular for treatment purposes. Based on the unprec-
edented rapid development of techniques for structural, functional, 
and molecular brain imaging, it has recently been suggested to 
incorporate standardized imaging inclusion criteria into future 
diagnostic systems such as the diagnostic and statistical manual 
of mental disorders (DSM-V) or the international classification of 
diseases system (ICD-11; Dubois et al., 2007; Hyman, 2007; Kipps 
et al., 2009).
Comprehensive meta-analyses are an excellent method of 
validating the impact of imaging markers on diagnosis and dif-
ferential diagnosis of dementia syndromes. Recently, we have iden-
tified the prototypical neural correlates of two frequent dementia 
disorders, Alzheimer’s disease (AD), and frontotemporal lobar 
degeneration (FTLD), in comprehensive systematic and quantita-
tive meta- analyses conducted according to the QUOROM state-
ment (Schroeter et al., 2007, 2009). These meta-analyses involved 
1618 patients and 1448 healthy control subjects and applied the 
anatomical likelihood estimate (ALE) method, which is regarded 
as the most sophisticated and best-validated of coordinate-based 
voxelwise meta-analyses (Fox et al., 2005; Glahn et al., 2008; Laird 
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inferior temporal poles and amygdalae – brain regions that have 
been discussed in the context of conceptual knowledge, semantic 
information processing, and social cognition. Progressive non-fluent 
aphasia (PNFA) involved the whole left frontotemporal network for 
phonological and syntactical processing. These meta-analytic results 
corresponded with other studies including also different imaging 
approaches and provided a basis for the understanding of clinical 
symptoms (Gorno-Tempini et al., 2004; Diehl-Schmid et al., 2007; 
Salmon et al., 2009; McDonald et al., 2010; Walhovd et al., 2010).
Besides the early detection of dementia syndromes, the dissocia-
tion of their neural correlates is crucial for their early differential 
diagnosis and treatment – an issue that is particularly relevant 
for the incorporation of standardized imaging inclusion criteria 
into future diagnostic systems (Dubois et al., 2007; Hyman, 2007; 
Kipps et al., 2009). While our previous meta-analyses identified the 
neural correlates of AD and FTLD (Schroeter et al., 2007, 2009), we 
now combine and synthesize these meta-analyses in a conjunction 
analysis in order to compare and dissociate the neural correlates 
of AD and FTLD, and to validate the specificity of imaging criteria 
for these disorders.
MaterIals and Methods
MedLine and Current Contents search engines were used to sys-
tematically identify studies on morphometry, glucose utilization, 
and perfusion in AD, MCI, and FTLD (Schroeter et al., 2007, 2009). 
Studies were examined to fulfil the following inclusion criteria: 
peer-reviewed, original studies, patients diagnosed according to 
internationally recognized diagnostic criteria, patients compared 
to age-matched healthy controls, or age included as a covariate in 
the analysis, quantitative automated whole brain analysis method, 
results normalized to a stereotactic space such as the Talairach or 
the Montreal Neurological Institute (MNI) reference system, and 
respective coordinates are available. When maxima were reported in 
the MNI reference system, they were transformed to the Talairach 
space. We also applied the following exclusion criteria. Studies using 
solely region-of-interest analysis were excluded to prevent any a 
priori assumptions with regard to the involved neural networks 
and to enable a data-driven approach, as were case studies, and 
studies investigating substantially overlapping patient populations. 
Moreover, we generally excluded functional imaging studies inves-
tigating brain activation during cognitive stimulation, because they 
apply diverse psychological paradigms making a comparison of 
the individual studies in a meta-analysis impossible. The literature 
search, selection of studies according to the inclusion and exclusion 
criteria and compilation of coordinates for the several contrasts 
were performed independently by two investigators and any disa-
greements were resolved by consensus.
Contrasts between patients and healthy control subjects were 
included, reporting either atrophy [magnetic resonance imaging 
(MRI)], decreases in glucose utilization [18F-fluorodeoxyglucose-
positron emission tomography (FDG-PET)], or perfusion [H
2
15O-
PET, 99mTc-hexamethylpropyleneamine oxime-(HMPAO)-single 
photon emission computed tomography (SPECT), 99mTc-ethyl-
cysteinate dimmer-(ECD)-SPECT]. Finally, for AD and MCI, 40 
studies were identified involving 1351 patients and 1097 healthy 
control subjects reporting either atrophy or decreases in glucose 
utilization and perfusion (see Schroeter et al., 2009). For FTLD, 19 
relevant studies were extracted measuring atrophy or decreases in 
glucose utilization in 267 patients and 351 healthy control subjects 
(see Schroeter et al., 2007). Here, the analysis was performed for 
each of the three subtypes as proposed by Neary et al. (1998): FTD, 
SD, and PNFA. No perfusion study fulfilled the inclusion criteria 
for FTLD. The meta-analysis flow charts, further information as 
required according to the QUOROM statement and the studies 
included are listed in detail in our previous papers (Schroeter et al., 
2007, 2009).
To extract the prototypical neural networks, we applied the ALE 
meta-analysis method (Turkeltaub et al., 2002; Fox et al., 2005; 
Schroeter et al., 2007, 2008, 2009; Glahn et al., 2008). The idea 
behind this method is to determine brain regions that exhibit a 
higher density of peak coordinates reported across studies than 
would arise by chance. Based on peaks of atrophy, hypometabolism 
or hypoperfusion as reported in the single studies, the algorithm 
calculates an ALE map that represents the likelihood for each voxel 
that at least one of the reported peaks is located there. ALE values 
were determined on a grid of isotropic 2mm × 2mm × 2 mm vox-
els. In a second step, these empirical ALE maps were compared to 
ALE maps for randomly distributed maxima. The same number 
of maxima as included in the empirical ALE map was uniformly 
distributed 1000 times over a brain volume mask. Histograms of 
the thousand sets of randomly distributed maxima were averaged 
to obtain a histogram representing the noise distribution of ALE 
values. This histogram served as a null hypothesis against which the 
significance of the empirical ALE values was tested. A conservative 
ALE threshold corresponding to a level of 0.01% (p < 0.0001) was 
chosen to reduce the probability of type I errors and to identify 
only the most consistent regions of atrophy, hypometabolism, and 
hypoperfusion (Turkeltaub et al., 2002). The null hypothesis of 
random distribution was rejected for the voxels that exceeded this 
threshold. Results of the ALE analysis separately for AD and FTLD 
as well as a detailed description of the method applied are reported 
elsewhere (Schroeter et al., 2007, 2008, 2009).
Here, we compare and dissociate the neural correlates of AD and 
FTLD by combining and synthesizing these recent comprehensive 
meta-analyses. Accordingly, a conjunction analysis was conducted 
across results for AD and FTLD, separately for the different imag-
ing approaches, namely MRI investigating atrophy and FDG-PET 
measuring changes in glucose utilization. Because the meta-analysis 
did not reveal any relevant study measuring changes in perfusion 
in FTLD, the conjunction analysis for AD and FTLD could not 
be performed for this imaging approach. A second conjunction 
analysis compared the results for the three imaging methods in AD 
alone. Here, a sufficient number of studies investigating atrophy 
(MRI), glucose utilization (FDG-PET), and perfusion (SPECT/
PET) were available.
results
deMographIc and clInIcal characterIstIcs
Table 1 illustrates the demographic and clinical characteristics of 
the different dementia cohorts involved in the meta-analysis. Note 
that we did not include subjects with amnestic MCI, because it is 
considered as a prodromal stage of AD and the FTLD subtypes 
may be associated with other non-amnestic prodromal stages 
such as dysexecutive MCI or mild behavioral (FTD) or language 
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state examination (MMSE) and no significant interaction between 
both factors (dementia subtype: F = 1.4, degrees of freedom, df = 3, 
p = 0.40; method: F = 0.3, df = 2, p = 0.77; interaction F = 1.3, 
df = 3, p = 0.29). One might conclude that the dementia subtypes 
did not show differences in dementia severity. The ANOVA for age 
showed a different result – namely the factor dementia subtype 
was significant (F = 10.8, df = 3, p = 0.04), whereas there was no 
significant impact of imaging methods or interaction between both 
factors (F = 27.1, df = 2, p = 0.84; F = 0.62, df = 3, p = 0.61). Post hoc 
analyses with unpaired Student’s t-tests revealed that patients with 
AD were older than patients with FTD or SD (T = −7.1, df = 22.2, 
T = −3.0, df = 39). Furthermore, patients with PNFA were older 
than those with FTD (T = −6.1, df = 9; p < 0.05; other comparisons 
not significant; two tailed p, Bonferroni corrected and adjusted for 
inequality of variance if necessary). Age differences between groups 
are in accordance with the literature – in particular later age at onset 
in PNFA in comparison with other FTLD subtypes (Johnson et al., 
2005) and increasing prevalence of AD with aging (Dubois et al., 
2007; Schroeter et al., 2009). Because the original studies generally 
controlled for effects of age, no impact of age on the results of the 
meta-analysis was assumed.
neural correlates of alzheIMer’s dIsease and 
frontoteMporal lobar degeneratIon
Figure 1 illustrates the neural correlates for the several demen-
tia syndromes as revealed by the ALE meta-analysis. Results are 
shown for the three imaging methods separately. AD affected a 
temporoparietal and frontomedian-thalamic network. For FTLD, 
the meta-analyses specifically isolated the neural substrates for 
its three subtypes. FTD involved a frontomedian and thalamic 














AD MRI, PET, 
Perf.
26 826 70.4 ± 4.8 20.4 ± 2.8
FTD MRI, PET 7 132 62.3 ± 2.1 20.1 ± 4.4
PNFA MRI, PET 4 38 69.0 ± 0.8 23.0 ± 2.0
SD MRI, PET 7 59 64.7 ± 3.1 23.2 ± 1.2
Mean ± SD. AD, Alzheimer’s disease; Co, controls; FTD, frontotemporal 
dementia; MMSE, mini-mental state examination; MRI, magnetic resonance 
imaging; Perf., perfusion; PET, 18F-fluorodeoxyglucose-positron emission 
tomography; PNFA, progressive non-fluent aphasia; SD, semantic dementia.
FIGuRE 1 | Results of the ALE meta-analyses identifying the neural 
correlates of Alzheimer’s disease (AD), frontotemporal dementia (FTD), 
progressive non-fluent aphasia (PNFA), and semantic dementia (SD). Atrophy 
as measured by magnetic resonance imaging (MRI) and decreases in glucose 
utilization as measured by 18F-fluorodeoxyglucose-positron emission tomography 
(FDG-PET) in patients compared with control subjects. For AD, reductions in 
perfusion are additionally shown (no studies available for FTD, PNFA, and SD). 
ALE – anatomical likelihood estimates. Coordinates in Talairach space. Left is left.
 impairment (PNFA and SD; Winblad et al., 2004). Further, we 
excluded studies focused on undifferentiated FTLD, where the 
specific subtype was not identified. Distribution of dementia 
subgroups in the meta-analyses corresponds with epidemiologi-
cal reports, because AD is the most frequent dementia syndrome 
(Dubois et al., 2007; Schroeter et al., 2009), whereas FTLD repre-
sents the second most common diagnosis of dementia in individu-
als younger than 65 years (Schroeter et al., 2007). It is also well 
known that approximately half of all FTLD diagnoses are FTD cases; 
SD and PNFA account for one quarter each (Johnson et al., 2005).
An ANOVA including dementia subtype (AD vs. FTD vs. PNFA 
vs. SD) as a between subjects factor and method (MRI vs. FDG-PET 
vs. perfusion) as an additional factor revealed no influences of both 
factors on severity of dementia as measured by the mini-mental 
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second conjunctIon analysIs – IMagIng In alzheIMer’s 
dIsease
The second conjunction analysis compared the neural correlates 
for AD alone as revealed by the respective three different imag-
ing approaches, measuring either atrophy (MRI), glucose utiliza-
tion (FDG-PET), or perfusion (SPECT/PET; Figure 2, bottom). 
Eight hundred twenty-six patients were included in this analysis. 
For detailed information with respect to the studies included see 
Schroeter et al. (2009). Regarding the AD cohorts of the studies apply-
ing the three different imaging approaches, there were no significant 
differences of dementia severity as rated with the MMSE. Again no 
impact of age on results of the conjunction analysis was assumed.
As illustrated in Figure 2, the analysis focusing on different 
imaging approaches in AD revealed a regional dissociation between 
atrophy as measured with MRI on the one side and hypoperfu-
sion (SPECT/PET) and hypometabolism (FDG-PET) on the other 
side. Both hypoperfusion (SPECT/PET) and hypometabolism 
(FDG-PET) coincided in the angular and supramarginal gyrus 
(Brodmann area 39 and 40). Additionally, perfusion and metabo-
lism were reduced in tightly adjoining areas in the inferior precu-
neus and posterior cingulate cortex (Brodmann area 7/31 and 23).
dIscussIon
Together with our recent findings (Schroeter et al., 2007, 2008, 
2009), the data suggest a specific dissociation of affected brain 
regions in AD and the three FTLD subtypes if different imaging 
 network. PNFA was related to a left frontotemporal network and 
the lentiform nucleus, whereas SD was associated with changes in 
the inferior temporal poles, amygdalae, and subcallosal area. Details 
of the involved anatomical structures and a discussion of their 
functional correlates may be found in Schroeter et al. (2007, 2009).
fIrst conjunctIon analysIs – alzheIMer’s dIsease vs. 
frontoteMporal lobar degeneratIon
Results of the conjunction analysis for the comparison between the 
neural correlates of AD and the three subtypes of FTLD are illus-
trated in Figure 2. Note that the conjunction analysis was conducted 
separately for the two relevant imaging approaches MRI and FDG-
PET. Because the meta-analysis did not reveal any relevant study 
measuring perfusion changes in FTLD, this conjunction analysis 
could not be performed for this imaging approach.
In the final analysis, 578 patients with AD and 229 patients with 
FTLD were included. For detailed information with respect to the 
studies included see Schroeter et al. (2007, 2009). There were no 
significant differences of dementia severity as rated with the MMSE 
between AD and FTLD cohorts (see above). The conjunction analy-
sis identified only one brain region bilaterally where atrophy as 
measured with MRI coincided in AD and the FTLD subtype SD 
(Figure 2, top). This region included the amygdala and hippocam-
pal head. The other brain regions did not show any overlap in AD 
and the FTLD subtypes for atrophy (MRI) or glucose utilization 
(FDG-PET).
FIGuRE 2 | Results of the conjunction analysis for Alzheimer’s disease (AD) 
and frontotemporal lobar degeneration (FTLD). Upper row: Atrophic brain 
regions overlap in AD and the FTLD subtype semantic dementia (SD) in both 
amygdalae and hippocampal heads (maximum/cluster size: left −26 −9 
−18/27 mm3, right 25 0 −21/243 mm3). No further overlap of atrophy (MRI) or 
changes in glucose utilization (FDG-PET) was found for AD and the three FTLD 
subtypes. Lower row: Abnormally low perfusion and glucose utilization overlap 
in AD in both angular and supramarginal gyri (left −47 −52 40/135 mm3, right 49 
−58 31/27 mm3) and affect tightly adjoining brain regions in the inferior 
precuneus and posterior cingulate cortex, whereas atrophy was regionally 
dissociated from these functional imaging measures. Coordinates in Talairach 
space. Left is left.
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 suggests (see for instance Seeley et al., 2009; Dukart et al., 2010; 
Raczka et al., 2010). Consequently, in single imaging studies the 
regional overlap between AD and FTLD might be larger than sug-
gested by our meta-analysis (particularly frontotemporal regions) – 
leading to generally less specific regional dissociations between both 
dementia syndromes. Moreover, the ALE meta-analysis might have 
missed parietal and posterior cingulate atrophy in AD as has been 
observed in single studies with MRI (Thompson et al., 2003).
However, for diagnostic purposes, the most consistent proto-
typical brain networks are of highest interest. Future classification 
systems for dementia require prediction, diagnosis, and differential 
diagnosis in individual subjects (Dubois et al., 2007; Hyman, 2007; 
Kipps et al., 2009). To address this issue we suggest focusing indi-
vidual image analyses, for instance with support vector machine 
classification, on the regions-of-interest that have been identified 
in our studies based on independent large patient cohorts (Klöppel 
et al., 2008; Wilson et al., 2009). Indeed, we could show recently in 
our own patient cohort that the accuracy of the individual diagnosis 
of AD and FTLD can be improved by applying this method with 
multimodal imaging including MRI and FDG-PET (Dukart et al., 
2011). These results supply first evidence that ALE meta-analytic 
based approaches may decisively improve the sensitivity and speci-
ficity in individual diagnosis of dementia syndromes – although 
results have to be confirmed by studies combining in vivo imaging 
with post mortem histopathological validation of dementia sub-
types – to date the golden standard of dementia diagnosis.
In conclusion, our data together with other imaging studies sug-
gest that combined brain imaging markers can reliably dissociate 
the most frequent neurodegenerative dementia disorders, AD, and 
FTLD. Results support the incorporation of standardized imaging 
inclusion criteria into future diagnostic systems, which will be cru-
cial for early diagnosis and treatment in the future (Dubois et al., 
2007; Hyman, 2007; Kipps et al., 2009).
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modalities are combined. MRI alone, if investigating atrophy, could 
not reliably dissociate AD and FTLD, because it revealed a common 
atrophic temporal brain region in AD and one subtype of FTLD, 
SD. However, this overlap might have no significant influence on 
reliable differential diagnosis in dementia syndromes if other imag-
ing markers in AD such as abnormally low glucose utilization and 
perfusion in the parietal lobes (Figure 1, bottom) are carefully taken 
into account (Dubois et al., 2007; Drzezga et al., 2008). Moreover, 
high amyloid plaque load in AD in contrast, among others, to SD 
might contribute to differentiating dementia disorders, although 
to date no ALE meta-analysis can be performed across amyloid 
imaging studies due to their limited number (Dubois et al., 2007; 
Drzezga et al., 2008).
As MRI is more easily available than SPECT or PET in clinical 
settings, one might prefer a reliable imaging approach for the differ-
ential diagnosis of dementia syndromes based only on this method. 
In this context, the results of the second conjunction analysis are of 
particular interest – namely the regional coincidence of changes in 
glucose utilization and perfusion in AD (beside their dissociation 
from regional atrophy in agreement with former studies; see for 
instance Luckhaus et al., 2010). Accordingly, combining two MRI 
approaches, morphometric MRI, and arterial spin labeling (ASL) 
MRI measuring atrophy and changes in perfusion might yield suf-
ficient information to dissociate AD and FTLD in the future (Alsop 
et al., 2010). Remarkably, a recent study underlines the importance 
of ASL in differentiating between AD and FTLD (Hu et al., 2010). 
In conclusion, due to its lack of specificity, structural MRI should 
be supported by other imaging modalities in the differential diag-
nosis of dementia.
Finally, one has to discuss the study’s limitations and prospects. 
Beside the three subtypes of FTLD as suggested by the classification 
of Neary et al. (1998) future meta-analyses should also include 
other closely related dementia types, i.e., corticobasal degeneration, 
progressive supranuclear palsy, and logopenic aphasia, once enough 
studies are available (Gorno-Tempini et al., 2004; Rabinovici and 
Miller, 2010; Seelaar et al., 2011). Furthermore, the method applied 
has to be discussed critically. Because ALE meta-analyses generally 
include maxima and not cluster sizes of the various studies, they 
extract the prototypical, most characteristic neural networks rep-
resenting the brain regions that are consistently involved in specific 
dementia syndromes. Accordingly, single studies might have shown 
that dementia disorders may affect other brain structures and 
may be regionally more unspecific than the present meta-analysis 
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